Revenue increased 10.6%
Revenue changed +10.6% from the comparable as-filed period.
$728.0M→$805.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →OKTA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents decreased 12.9%
Cash & equivalents changed -12.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$876.0M→$763.0M2 prior comparisons
Free-cash-flow margin moved 628 bp higher
Free-cash-flow margin changed +628 basis points from the comparable as-filed period.
22.66%→28.94%2 prior comparisons
Operating cash-flow margin moved 613 bp higher
Operating cash-flow margin changed +613 basis points from the comparable as-filed period.
22.94%→29.07%2 prior comparisons
Gross profit increased 14.5%
Gross profit changed +14.5% from the comparable as-filed period.
$560.0M→$641.0M2 prior comparisons
Stock-based compensation decreased 20.8%
Stock-based compensation changed -20.8% from the comparable as-filed period.
$144.0M→$114.0M2 prior comparisons
Capital expenditure decreased 50.0%
Capital expenditure changed -50.0% from the comparable as-filed period.
$2.0M→$1.0M3 prior comparisons
Current assets decreased 13.4%
Current assets changed -13.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.6B→$3.1B4 prior comparisons
Working capital increased 15.8%
Working capital changed +15.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$919.0M→$1.1B4 prior comparisons
R&D / revenue moved 173 bp lower
R&D / revenue changed -173 basis points from the comparable as-filed period.
21.98%→20.25%2 prior comparisons
Working capital / assets moved 202 bp higher
Working capital / assets changed +202 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
9.62%→11.64%4 prior comparisons
Total assets decreased 4.3%
Total assets changed -4.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$9.6B→$9.1B4 prior comparisons
Receivables / revenue moved 98 bp higher
Receivables / revenue changed +98 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
57.28%→58.26%2 prior comparisons
Research & development increased 1.9%
Research & development changed +1.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$160.0M→$163.0M2 prior comparisons
Capex / revenue moved 15 bp lower
Capex / revenue changed -15 basis points from the comparable as-filed period.
0.27%→0.12%2 prior comparisons
Current ratio increased 13.2%
Current ratio changed +13.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
1.35→1.534 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.